7/4/2025AstraZeneca Eyes $15B Deal for Summit's Chinese-Developed Lung Cancer ...

7/3/2025Vaccine Sales Collapse in China as MNCs Struggle with Local Competitio...

7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...

7/2/2025NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...

7/2/2025Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...

7/1/2025Biological E and China's Recbio Partner to Bring HPV9 Vaccine to India...

7/1/2025Hengrui's Ivarmacitinib Approved in China for Severe Alopecia Areata

7/1/2025Revolution Medicines and Summit Therapeutics Launch RAS-Targeting Comb...

6/30/2025CDE Reopens Public Consultation on Revised Technical Guidelines for Co...

6/27/2025Theravance Partner Viatris Lands NMPA Approval for YUPELRI, Unlocking ...

6/26/2025Vor Bio Secures ex-China Global Rights to RemeGen's Telitacicept

6/23/2025Sciwind's Ecnoglutide Achieves 15.4% Weight Loss in Chinese Obesity Ph...

6/20/2025CanSinoBIO Obtained NDA Approval for its 13-Valent Pneumococcal Polysa...

6/17/2025NMPA Holds Meeting to Review QMS in Vaccine Regulation, Pharma Manufa...

6/12/2025Dizal to Showcase Breakthrough Data on Hematologic Oncology Assets at ...

6/12/2025Viatris Wins NMPA Approval for Once‑Daily Nebulized COPD Therapy Yupe...

6/10/2025Gavi Launches $224M Arbitration Claim Against Clover Biopharma Over CO...

6/9/2025Sihuan's Chinese NDA for Breast Cancer Drug Bireociclib Accepted

6/6/2025AbbVie's Rinvoq (Upadacitinib) Gains Approval in China for Giant Cell ...

6/4/2025China Approves First Homegrown 9-Valent HPV Vaccine

6/3/2025Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval

5/31/2025Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...

5/31/2025Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...

5/31/2025China Approves First Homegrown Nine-Valent HPV Vaccine

5/29/2025Novartis Secures NMPA Approval for Beovu for DME in China

5/29/2025China Approves Two New CDK4/6 Inhibitors for Advanced Breast Cancer

5/29/2025China Approves Zelgen's Gecacitinib

5/29/2025China Grants Conditional Approval to Hengrui's Famitinib

5/29/2025CDE Solicits Comments on Draft Technical Considerations for NMR Studi...

5/27/2025RemeGen's Telitacicept Gains Approval in China

Page:2/74 Total number of articles:2197: [First][<<] [1] [2] [3] [4] [5] [>>] [End]